Has Yong Lin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,658 in general payments to Yong Lin, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yong Lin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yong Lin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yong Lin, MD

Pain Medicine · West Hollywood, CANPI 1649266479

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $384 and has fallen 63.3% since, to $141 in 2025. That places this record below the midpoint for pain medicine clinicians in CA, where the typical reported total is $1,829.

$1,658in general payments, 2019–2025

Across 27 payments — averaging $61.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pacira Therapeutics, Inc.$191
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$183
Gilead$170
Johnson & Johnson$166
Merck$143
Fisher & Paykel Healthcare Inc$141
plus $665 from 11 others

What the payments were for

Food & beverage$1,658100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pacira Therapeutics, Inc.	2	$191
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$183
Gilead	2	$170
Johnson & Johnson	3	$166
Merck	2	$143
Fisher & Paykel Healthcare Inc	1	$141
Averitas Pharma Inc.	2	$112
Pfizer	1	$82
Vertex	1	$80
Biodelivery Sciences International, Inc.	1	$76
Redhill Biopharma Inc.	1	$71
Collegium Pharmaceutical, Inc.	1	$54
Scilex Pharmaceuticals Inc.	3	$46
Emergent Biosolutions Inc.	1	$45
GRT US Holding, Inc.	1	$45
AbbVie	1	$36
Baudax Bio Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,658 in reported general payments places this provider in the 45th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Medicare billing

Part B allowed, 2024

$87,532

Medicare patients

278

Services billed

1,025

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OxycontinOxycodone Hcl	11	$3,327
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	170	$2,130
Gabapentin	135	$1,902
Lidocaine	15	$1,791
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	64	$986
Naloxone Hcl	17	$983
Diclofenac Sodium	21	$788
Tramadol Hcl	137	$722
Pregabalin	36	$689
Methocarbamol	107	$677
Duloxetine Hcl	43	$617
Cyclobenzaprine Hcl	61	$454
Celecoxib	23	$395
Carisoprodol	37	$355
Baclofen	32	$336

Paid to pharmacies, not to this prescriber.

Other pain medicine in West Hollywood

Howard RosnerWest Hollywood$79K
Jason PopeSanta Rosa$2.1M
Ramana NaiduLarkspur$1.4M
Foead GeulaStudio City$1.3M
Krishnan ChakravarthyTemecula$1.3M
Kasra AmirdelfanWalnut Creek$783K
Eric GrigsbyNapa$499K
Jacqueline WeisbeinNapa$494K
Gerald SacksSanta Monica$389K
Samir ShethRoseville$356K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →